San Francisco, CA, United States of America

Edwin L Madison

This inventor holds 36 USPTO granted patents and 4 published patent applications, plus 6 CIPO patents and 16 EPO patents, primarily in Serine Protease Modifications. Top assignees: Catalyst Biosciences, Inc., Dendreon Corporation, Corvas International, Inc.. Active years: 2003-2025.

USPTO Granted Patents = 36 (Patent Applications = 4)

% Patents Active = 72.2

CIPO Patents = 6

EPO Patents = 16 (Patent Applications = 13)

Average Co-Inventor Count = 2.3

ph-index = 9

Forward Citations = 284(Granted Patents)

Location History:

Del Mar, CA (US) (2003 - 2004)
San Diego, CA (US) (2003 - 2011)
San Francisco, CA (US) (2007 - 2023)

Company Filing History:

16 out of 26

Catalyst Biosciences, Inc.

Corvas International, Inc.

patents

4. 4 out of 1,167

Vertex Pharmaceuticals, Inc.

patents

5. 2 out of 1,203

Scripps Research Institute

patents

6. 2 out of 45

Torrey Pines Institute for Molecular Studies

Dendreon San Diego LLC

where one patent can have more than one assignee

Years Active: 2003-2025

Loading Chart...

Areas of Expertise:

Serine Protease

MTSP-1

Plasminogen Activator

Factor IX

Factor VII

Protease Inhibitors

Nucleic Acids

Transmembrane Proteases

Endotheliases

Polypeptides

Binding Proteins

Protease Screening

36 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12331334 - Modified urokinase-type plasminogen activator polypeptides and methods of use (2025-06-17),

2. 12173337 - Nucleic acid encoding modified membrane type serine protease 1 (MTSP-1) polypeptides and methods of use (2024-12-24),

3. 11807882 - Modified membrane type serine protease 1 (MTSP-1) polypeptides and methods of use (2023-11-07),

4. 11613744 - Modified urokinase-type plasminogen activator polypeptides and methods of use (2023-03-28),

5. 11401513 - Modified membrane type serine protease 1 (MTSP-1) polypeptides and methods of use (2022-08-02),

6. 11203749 - Factor VII polypeptides that are modified and uses thereof (2021-12-21),

7. 10982203 - Modified factor IX polypeptides and uses thereof (2021-04-20),

8. 10954501 - Nucleic acid encoding modified membrane type serine protease 1 (MTSP-1) polypeptides and methods of use (2021-03-23),

9. 10781435 - Modified membrane type serine protease 1 (MTSP-1) polypeptides and methods of use (2020-09-22),

10. 10160961 - Factor VII polypeptides that are modified and uses thereof (2018-12-25),

11. 9856467 - Modified factor X polypeptides and uses thereof (2018-01-02),

12. 9795655 - Modified MT-SP1 proteases that inhibit complement activation (2017-10-24),

13. 9476037 - Factor VII polypeptides that are modified and uses thereof (2016-10-25),

14. 9328339 - Modified factor IX polypeptides and uses thereof (2016-05-03),

15. 9290757 - Protease screening methods and proteases identified thereby (2016-03-22),

Title: The Innovative Mind of Edwin L Madison: Pioneering Advancements in Biomedical Science

Introduction: Edwin L Madison, a renowned inventor based in San Francisco, CA, is a trailblazer in the field of biomedical science, with an impressive portfolio of 34 patents to his name. His groundbreaking work has revolutionized the treatment of various diseases and conditions, making him a key figure in the world of innovation.

Latest Patents: Among his latest patents are Modified Membrane Type Serine Protease 1 (MTSP-1) polypeptides and Modified Urokinase-Type Plasminogen Activator polypeptides. These inventions are designed to inhibit complement activation, offering new treatment possibilities for a range of disorders such as ischemic and reperfusion disorders, autoimmune diseases, ophthalmic disorders, and transplanted organ rejection.

Career Highlights: Edwin L Madison has made significant contributions to the field of biomedical science through his work at companies like Catalyst Biosciences, Inc. and Dendreon Corporation. His commitment to innovation and problem-solving has led to the development of cutting-edge technologies that have the potential to impact countless lives.

Collaborations: Throughout his career, Edwin L Madison has collaborated with esteemed professionals in the field, including Christopher D Thanos and Edgar Ong. These collaborations have fostered a spirit of creativity and collaboration, leading to the successful realization of innovative ideas and solutions.

Conclusion: In conclusion, Edwin L Madison stands as a visionary inventor whose dedication to advancing biomedical science has transformed the landscape of healthcare. His relentless pursuit of innovative solutions and his collaborations with industry experts underscore his status as a pioneer in the field. Edwin L Madison's work serves as a testament to the power of innovation and the impact it can have on society.